Skip to main content

Savant Capital, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1482880 ROCKFORD, IL

Position in REGN

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$2,298,991
+$799,297 QoQ
Shares Held
3,687
+90.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#499
of 1,322 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority Sole 57% Shared 12% None 31%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Savant Capital, LLC holds $23,538,035 across 24 Biotechnology names. REGN ranks #2 (9.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
3,687 $2,298,991

All Filings in REGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,298,991 3,687
2026-03-31 $1,499,694 1,941
2025-12-31 $1,585,420 2,054
2025-09-30 $836,657 1,488
2025-06-30 $450,975 859
2025-03-31 $564,464 890
2024-12-31 $701,645 985
2024-09-30 $854,658 813
2024-06-30 $655,842 624
2024-03-31 $528,407 549
2023-12-31 $451,441 514
2023-09-30 $326,715 397
2023-06-30 $266,578 371
2023-03-31 $300,731 366
2022-09-30 $221,816 322
2022-03-31 $226,288 324
2020-06-30 $224,514 360